|
Published by: Datamonitor
Published: Dec. 18, 2001 - 168 Pages
Table of Contents
CHAPTER 1 EXECUTIVE SUMMARY
Introduction
Market context
Customer focus
Competitor dynamics
The future decoded
Action points
CHAPTER 2 INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
Methodology
Research and analysis methodology
Category and product definitions
CHAPTER 3 MARKET CONTEXT
Introduction
Key findings
Historical context
Trends in functional and fortified food and drink since the 1970s
Functional soft drinks
Key nutraceutical functions
Key consumer drivers
Emergence of ‘On-The-Go’ society
Better health education amongst consumers
The growing 35+ age bracket is driving medical nutraceuticals
Manufacturer drivers
Food and drink companies
Pharmaceutical companies
Company alliance may be the key strategy
Obstacles
Conclusions
CHAPTER 4 CUSTOMER FOCUS
Introduction
Key findings
Bone health
Osteoporosis
Joint pain/Arthritis
Diabetes
Overweight and Obesity
Disease definition
Pregnancy and breastfeeding
Pregnancy
Breastfeeding
Cardiovascular disease
Prevalence of cardiovascular disease
Cancer
Risk reduction through diet
Cancer nutraceutical market presents the biggest opportunity for manufacturers
Gastrointestinal/ digestive disorder
“Live culture” is alive
Menopause
Conclusions
CHAPTER 5 COMPETITIVE DYNAMICS
Introduction
Key findings
NPD trends
Geographical incidence
Delivery vehicle analysis
Function analysis
Positioning analysis
Shelving analysis
New Nutraceutical products
Case Studies
Mead Johnson Nutritionals: Viactiv Calcium Chews
Nestlé's LC1, Europe
Marketing strategy
SWOT analysis
CHAPTER 6 FUTURE DECODED
Introduction
Key findings
Channels of distribution for nutraceutical products
Key success criteria
Key consumer attitude factors
CHAPTER 7 ACTION POINTS
Introduction
Identify the function - prevention versus treatment
Choose the right condition
Support for health claims better
Focus on consumer occasions
CHAPTER 8 APPENDIX
European regulatory framework
PARNUTS
Foods with Positive Health Claims
US regulatory framework
The Nutrition Labeling and Education Act (NLEA)
The Dietary Supplement Health and Education Act (DSHEA)
LIST OF TABLES
Table 1: Key definitions
Table 2: Population (m), by country, by age group, 1995-2005
Table 3: Prevalence of osteoporosis, 2001
Table 4: Diabetes prevalence (per 100,000 population) by country, 1998 - 2005
Table 5: Approved drugs for the treatment of obesity, US, 1997-99
Table 6: Congestive Heart Failure (CHF) prevalence by country, 1998 - 2005
Table 7: Congestive Heart Failure (CHF) prevalence (per 100,000 population) by country, 1998 - 2005
Table 8: Expenditure on pharmaceuticals for heart disease (US$m), 1997 - 98
Table 9: Per head expenditure on pharmaceuticals for heart disease (US$/Head), 1997 - 98
Table 10: Percentage cancer prevalence by type, 1998 - 2000
Table 11: Cancer prevalence by type (per 100,000 population*), 1998 - 2005
Table 12: Top ten list of health concerns
Table 13: Common ingredients used in nutraceuticals
Table 14: Geographical distribution of new product launches
Table 15: Frequency of new product launches by market
Table 16: % Frequency of new product launches by use, by market
Table 17: Frequency of new product launches by category
Table 18: New medical nutraceutical launches, by function, by key ingredients
Table 19: Specific positioning of new medical nutraceutical launches
Table 20: New nutraceutical launches by function and shelving type
Table 21: New medical nutraceutical product launches between March 2000 and October 2001
Table 22: Viactiv, product range
Table 23: Proposed conditions for nutrient and functional claims
LIST OF FIGURES
Figure 1: The expanding realm of nutraceuticals
Figure 2: Key nutraceutical market drivers
Figure 3: Key consumer groups
Figure 4: The expanding realm of nutraceuticals
Figure 5: Datamonitor’s Research Methodology
Figure 6: Product trends since the 1970s
Figure 7: Key nutraceutical functions
Figure 8: Population growth by age group, across all covered countries, 1995-2005
Figure 9: Pressures on food and drinks to drive sales
Figure 10: Food and drink company, SWOT analysis for the nutraceutical market
Figure 11: The increasing cost of drug development
Figure 12: Key company types in the nutraceuticals market
Figure 13: Key nutraceutical market drivers
Figure 14: Age related changes in bone mass
Figure 15: Defining the patient population in diabetes, 2000
Figure 16: Weight status for BMI
Figure 17: Cardiovascular disease overview
Figure 18: Hypertensive patient population in the seven major markets, 2000
Figure 19: Prevalence of hypertension, 2000, core countries
Figure 20: Soy-based food products, SWOT analysis
Figure 21: Future outlook for the nutraceutical products
Figure 22: Hypothesized path of nutraceutical development
Figure 23: Frequency of new product launches by market
Figure 24: Medical products by function, by active ingredients
Figure 25: Viactiv Calcium Chews, packaging analysis
Figure 26: Viactiv Calcium Chews, SWOT analysis
Figure 27: LC1 Go probiotic drink
Figure 28: LC1 range of dairy products
Figure 29: LC1, SWOT analysis
Figure 30: Key consumer groups
Figure 31: Key distribution channels for nutraceuticals
Figure 32: Key success criteria
Figure 33: Key consumer attitude factors
Figure 34: Scope for medical nutraceutical opportunities
AbstractAlthough dietary supplements are sometimes counted as nutraceuticals, in the definition used in these reports, they are considered as a separate entity. The benefits they offer, which are directly between the therapeutic and the nutritional in maintaining balance are in direct competition with fortified food and drink products. Examples of this include the use of active ingredients such as calcium, omega 3&6, caffeine, perilla, ginseng and multivitamins, which are designed to provide similar benefits to dietary supplements.
OTC medicine faces the most immediate threat from nutraceuticals. It is clear that prescription medicines do also face a threat from nutraceuticals, although less overtly than OTC medicines. The most obvious threat is posed by brands such as Benecol, which has direct health benefits that could impact on a lucrative pharmaceutical market, namely patients with cardiovascular problems. However, manufacturers are targeting consumers with products that are essentially prophylactic, rather than curative, such as products that aim to help in the prevention of cancer, diabetes, cardiovascular diseases and other pharmaceutical staples. The long-term effect of higher take-up of nutraceuticals could have a significant impact on sales of conventional medicines if (and only if) such products are successful. Functional Food & Drinks for Specific Conditions & Ailments analyses the opportunities and threats in this area, with an extensive analysis of new product development in this highly lucrative segment of the nutraceuticals market.
Get Full Details About This Report >>
|
